Penumbra Launches Midway Intermediate Catheters for Neuroembolization Interventions

May 7, 2024—Penumbra, Inc. announced the launch of the Midway 43 and Midway 62 delivery catheters, which are designed to provide tracking and a stable platform to support the delivery of various embolization therapies in the neurovasculature. These Midway intermediate catheters are based on Penumbra’s Red catheter technology.

According to the company, the new Midway catheters are compatible with Penumbra’s Benchmark 71, BMX81, and BMX96 access systems. The devices are engineered to enable the precise delivery of distal microcatheters, embolization coils, intrasaccular devices, and flow diverters. They feature an advanced catheter design, full-length polytetrafluoroethylene liner, and distal hydrophilic coating.

John Chaloupka, MD, who is Section Chief of the Division of Neuro Interventional/Neuro Endovascular Surgery at Mount Sinai Medical Center in New York, New York, commented on the launch of the Midway devices in Penumbra’s announcement.

“The field of neuroendovascular surgery continues to evolve and expand in both scope and expectations of efficacy, creating increasing demands for technical efficiency and safety,” stated Dr. Chaloupka. “This trend is taking operators into more challenging technical scenarios, such as microcatheterization into far distal target lesions, tortuous intracranial vasculature, and unfavorable aortic arch/neck anatomy.”

He continued, “As such, use of so-called ‘intermediate access guiding catheters’ has become an important technological requirement towards achieving these goals. Penumbra’s portfolio of Midway intermediate catheters now provides us with highly engineered technology that provides an optimal balance of support and trackability in a wide range of applications.”